![Lena Mårtensson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lena Mårtensson
Direktor/Vorstandsmitglied bei
Xinnate AB
Profil
Lena Mårtensson is currently the Senior Director & Head-Pipeline Sourcing at LEO Pharma AB, the Director at Xinnate AB, the Director at Transient Pharma AB, the Head-Preclinical Unit at Gambro AB, and an Associate Professor at the University of Lund.
She is also a Partner at Aqilion AB since 2015.
Previously, she worked as a Director at Cereno Scientific AB.
Aktive Positionen von Lena Mårtensson
| Unternehmen | Position | Beginn |
|---|---|---|
Aqilion AB
 Aqilion AB Investment ManagersFinance Aqilion AB is an active manager which invests companies located in Sweden. The firm follows of life science companies. It provides financing for early-stage capital requirements. | Private Equity Investor | 12.11.2015 |
Gambro AB
 Gambro AB Medical SpecialtiesHealth Technology Develops and manufactures dialysis equipment and blood purification products | Corporate Officer/Principal | - |
LEO Pharma AB
 LEO Pharma AB LEO Pharma AB is an independent, Swedish research-driven pharmaceutical company specializing in dermatology, with a history spanning over 100 years from its origins in Copenhagen. The company is based in Malmö, Sweden. The company employs approximately 5,200 people worldwide and serves 92 million patients across 130 countries. LEO Pharma is majority-owned by the independent LEO Foundation, with Nordic Capital holding a minority stake. Its Nordic hub operates in Sweden, with about 25 employees focused on sales, marketing, medical affairs, and supply. The company’s product portfolio includes dermatological and thrombotic treatments. | Corporate Officer/Principal | - |
Xinnate AB | Direktor/Vorstandsmitglied | - |
Transient Pharma AB | Direktor/Vorstandsmitglied | - |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Lena Mårtensson
| Unternehmen | Position | Ende |
|---|---|---|
| CERENO SCIENTIFIC AB | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
86
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Gambro AB
Gambro AB Medical SpecialtiesHealth Technology Develops and manufactures dialysis equipment and blood purification products | Health Technology |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aqilion AB
Aqilion AB Investment ManagersFinance Aqilion AB is an active manager which invests companies located in Sweden. The firm follows of life science companies. It provides financing for early-stage capital requirements. | Finance |
LEO Pharma AB
LEO Pharma AB LEO Pharma AB is an independent, Swedish research-driven pharmaceutical company specializing in dermatology, with a history spanning over 100 years from its origins in Copenhagen. The company is based in Malmö, Sweden. The company employs approximately 5,200 people worldwide and serves 92 million patients across 130 countries. LEO Pharma is majority-owned by the independent LEO Foundation, with Nordic Capital holding a minority stake. Its Nordic hub operates in Sweden, with about 25 employees focused on sales, marketing, medical affairs, and supply. The company’s product portfolio includes dermatological and thrombotic treatments. | |
Cereno Scientific AB
 Cereno Scientific AB Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | Health Technology |
Xinnate AB | |
Transient Pharma AB |
Wählen Sie MarketScreener 
